PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Erythromycin ethylsuccinate
Presentation Product Chemical substance Chapter Items dispensed
Erythromycin ethyl succinate 250mg/5ml susp sugar free
0501050H0AAAMAM
Erythromycin ethylsuccinate Erythromycin ethylsuccinate Infections 14,389
Erythromycin ethyl succinate 250mg/5ml oral suspension
0501050H0AAABAB
Erythromycin ethylsuccinate Erythromycin ethylsuccinate Infections 14,353
Erythromycin ethyl succinate 125mg/5ml susp sugar free
0501050H0AAALAL
Erythromycin ethylsuccinate Erythromycin ethylsuccinate Infections 8,018
Erythromycin ethyl succinate 125mg/5ml oral suspension
0501050H0AAAAAA
Erythromycin ethylsuccinate Erythromycin ethylsuccinate Infections 7,082
Erythromycin ethyl succinate 500mg tablets
0501050H0AAAEAE
Erythromycin ethylsuccinate Erythromycin ethylsuccinate Infections 2,934
Erythromycin ethyl succinate 500mg/5ml oral suspension
0501050H0AAACAC
Erythromycin ethylsuccinate Erythromycin ethylsuccinate Infections 738
Erythromycin ethyl succinate 500mg/5ml susp sugar free
0501050H0AAANAN
Erythromycin ethylsuccinate Erythromycin ethylsuccinate Infections 318
Erythroped SF 250mg/5ml oral suspension
0501050H0BDAMAM
Erythroped Erythromycin ethylsuccinate Infections 20
Erythroped PI SF 125mg/5ml oral suspension
0501050H0BDANAL
Erythroped Erythromycin ethylsuccinate Infections 17
Erythroped A 500mg tablets
0501050H0BDAIAE
Erythroped Erythromycin ethylsuccinate Infections 7
Erythroped Forte SF 500mg/5ml oral suspension
0501050H0BDAPAN
Erythroped Erythromycin ethylsuccinate Infections 2

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.